An Aspartyl Cathepsin Targeted PET Agent: Application in an Alzheimer's Disease Mouse Model.
Author | |
---|---|
Abstract | :
Early detection of Alzheimer's disease (AD) pathology is a serious challenge for both diagnosis and clinical trials. The aspartyl protease, Cathepsin D (CatD), is overexpressed in AD and could be a biomarker of disease. We have previously designed a unique contrast agent (CA) for dual-optical and magnetic resonance imaging of the activity of the CatD class of enzymes. |
Year of Publication | :
0
|
Journal | :
Journal of Alzheimer's disease : JAD
|
Volume | :
61
|
Issue | :
3
|
Number of Pages | :
1241-1252
|
Date Published | :
2018
|
ISSN Number | :
1387-2877
|
URL | :
https://content.iospress.com/openurl?genre=article&id=doi:10.3233/JAD-170115
|
DOI | :
10.3233/JAD-170115
|
Short Title | :
J Alzheimers Dis
|
Download citation |